Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Cardiovascular Risk Factors, Including Endothelial Function, After Restoration of Normoglycemia Following Single Pancreas Transplantation

NCT02066350 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT02066350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02066350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Cardiovascular Risk Factors, Including Endothelial Function, After Restoration of Normoglycemia Following Single Pancreas Transplantation
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2014
Completion date
February 28, 2017
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type 1, endothelial dysfunction